Daily Financial Update Market Pulse: Crypto got clubbed yesterday, with Dogecoin failing to bounce, XRP bleeding its intraday structure and Ethereum tagging along. Meanwhile India’s Nifty drifts against its 26,000 gatekeeper. Key...
Latest articles
BMY: Trial Disappointment Could Sink Shares Further!
Overview Bristol Myers Squibb (NYSE: BMY) is facing significant headwinds as it transitions through a challenging period. The pharmaceutical giant has seen its share price under pressure amid a confluence of negative factors –...
Nifty Breakout Sparks Swing Trades Amid Crypto Whales
Market Pulse: Nifty slices through its 50-day moving average and layered bullish momentum into the session, hinting at fresh swing trade setups while crypto markets stir back to life after summer stagnation. Key Movers: Axis...
Cramer’s Take on T: Why Now’s the Time to Buy!
Introduction: CNBC’s Jim Cramer recently argued that AT&T (NYSE: T) is “worth owning,” citing a truce in the telecom price wars and the stock’s strong yield with improving earnings ([1]). AT&T’s core wireless and broadband...
Crypto Selloff Sparks Volatility: Trading Playbook Inside
Opening Recap Market Pulse: Tech dragged major indexes into the red as rate-cut hopes slipped, while crypto tumbled and India’s benchmark staged a comeback rally. Key Movers: Momentum names on the Nasdaq and S&P led the downturn...
All Eyes On NVDA: Whipsaw Week Sparks Big Opportunity!
Introduction NVIDIA Corporation (NASDAQ: NVDA) has been at the epicenter of the AI-driven market boom, delivering astonishing financial growth. Fiscal 2024 was a breakout year – revenue surged 126% to $60.9 billion, with net...
Bitcoin Crash Sparks Altcoin Buying Frenzy
Opening Recap Market Pulse: Crypto markets took a hit after Bitcoin crashed below key thresholds, dragging risk appetite lower across digital and traditional fronts. Key Movers: Bitcoin crashes below $97,000 (Coinjournal.net)...
GILD: One-Pill HIV Breakthrough Could Change Everything!
Company Overview and HIV Leadership Gilead Sciences (NASDAQ: GILD) is a $150+ billion biopharmaceutical company best known for its pioneering treatments in HIV/AIDS ([1]). Over the past decades, Gilead transformed HIV care by...
Volatile Markets Ahead: Urban Company Tanks and XRP Soars
Daily Financial Update Market Pulse: Yesterday's session went off the rails as new issues and crypto-linked ETFs roiled risk assets, with Urban Company slipping roughly 30% off highs and XRP action igniting fresh volatility. Key...
AERO: Court Ruling Paves Way for Major Comeback!
Introduction and Legal Victory AerCap Holdings N.V. (NYSE: AER), the world’s largest aircraft leasing company, faced a major setback in 2022 when the Russia-Ukraine conflict left dozens of its aircraft stranded in Russia ([1])...